Why Neurocrine Biosciences Stock Sank Today
Portfolio Pulse from
Neurocrine Biosciences' stock fell over 3% after three analysts lowered their price targets, despite the company reporting better-than-expected profitability in the fourth quarter.
February 10, 2025 | 11:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neurocrine Biosciences' stock declined over 3% as three analysts reduced their price targets, overshadowing the company's strong Q4 profitability.
The stock price of Neurocrine Biosciences fell due to negative sentiment from analysts who lowered their price targets. This negative sentiment outweighed the positive news of better-than-expected Q4 profitability, leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100